Cutler Group’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $31K | Buy |
+800
| New | +$31K | 0.01% | 467 |
|
|
2023
Q2 | – | Sell |
-353
| Closed | -$2K | – | 1476 |
|
|
2023
Q1 | $2K | Hold |
353
| – | – | ﹤0.01% | 1237 |
|
|
2022
Q4 | $1K | Hold |
353
| – | – | ﹤0.01% | 1612 |
|
|
2022
Q3 | $1K | Hold |
353
| – | – | ﹤0.01% | 1794 |
|
|
2022
Q2 | $2K | Hold |
353
| – | – | ﹤0.01% | 1702 |
|
|
2022
Q1 | $5K | Hold |
353
| – | – | ﹤0.01% | 1676 |
|
|
2021
Q4 | $6K | Hold |
353
| – | – | ﹤0.01% | 1773 |
|
|
2021
Q3 | $10K | Hold |
353
| – | – | ﹤0.01% | 1699 |
|
|
2021
Q2 | $19K | Hold |
353
| – | – | ﹤0.01% | 1541 |
|
|
2021
Q1 | $20K | Hold |
353
| – | – | ﹤0.01% | 1470 |
|
|
2020
Q4 | $13K | Sell |
353
-127
| -26% | -$4.68K | ﹤0.01% | 1384 |
|
|
2020
Q3 | $25K | Buy |
+480
| New | +$25K | ﹤0.01% | 1086 |
|
|
2019
Q1 | – | Sell |
-42
| Closed | -$7K | – | 1604 |
|
|
2018
Q4 | $7K | Sell |
42
-9
| -18% | -$1.5K | ﹤0.01% | 1303 |
|
|
2018
Q3 | $11K | Buy |
+51
| New | +$11K | ﹤0.01% | 1276 |
|
|
2018
Q2 | – | Sell |
-180
| Closed | -$32K | – | 1750 |
|
|
2018
Q1 | $32K | Sell |
180
-232
| -56% | -$41.2K | ﹤0.01% | 1072 |
|
|
2017
Q4 | $87K | Buy |
412
+359
| +677% | +$75.8K | ﹤0.01% | 905 |
|
|
2017
Q3 | $11K | Sell |
53
-252
| -83% | -$52.3K | ﹤0.01% | 1857 |
|
|
2017
Q2 | $57K | Buy |
305
+76
| +33% | +$14.2K | ﹤0.01% | 1419 |
|
|
2017
Q1 | $56K | Sell |
229
-196
| -46% | -$47.9K | ﹤0.01% | 1428 |
|
|
2016
Q4 | $107K | Buy |
425
+392
| +1,188% | +$98.7K | ﹤0.01% | 1161 |
|
|
2016
Q3 | $6K | Buy |
+33
| New | +$6K | ﹤0.01% | 2327 |
|